ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ANIP vs CMPS // RSI-14 & 200D SMA MOMENTUM

ANI Pharmaceuticals Inc. (NASDAQ) VS. COMPASS Pathways Plc American Depository Shares (NASDAQ) • 15-METRIC TALLY: ANIP 5 — CMPS 1
▲ RSI-14 & 200D SMA MOMENTUM LEADER: ANIP
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ANIP VS. CMPS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ANIP CMPS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 16.00% -35.00% +51.00 ANIP /roic <GO>
EV/EBITDA & P/E Valuation 13.7x — — TIE /valuation <GO>
Free Cash Flow Yield 10.20% -9.31% +19.51 ANIP /fcf-yield <GO>
Operating Margin 12.60% — — TIE /operating-margins <GO>
Net Profit Margin 8.80% — — TIE /net-margins <GO>
Revenue Growth (YoY) 43.80% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.07% 0.00% +0.07 ANIP /dividend-safety <GO>
Altman Z-Score & Debt/Equity 2.36 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 8/9 1/9 +7.00 ANIP /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum ACTIVE 47.2 45.5 +1.62 ANIP /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 18.1x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.68B $1.69B -$8.3M CMPS /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ANIP REV CMPS REV ANIP GROSS % CMPS GROSS % ANIP FCF CMPS FCF
FY 2025 $883.4M $0 — — $171.4M -$157.2M
FY 2024 $614.4M $0 — — $47.8M -$119.2M
FY 2023 $486.8M $0 — — $119.0M -$97.4M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ANIP // BETA —
CMPS // BETA —